Stay updated on DCVax-L for Newly Diagnosed GBM Clinical Trial

Sign up to get notified when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DCVax-L for Newly Diagnosed GBM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the DCVax-L glioblastoma trial is displayed, with study design, eligibility requirements, participating locations, investigators, and outcome measures. It replaces the prior access-denied page.
    Difference
    84%
    Check dated 2026-11-08T15:22:38.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:25:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide announcement says NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:37:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to display a 403 Forbidden error; its footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:20:47.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:11:46.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, with the content replaced by a standard header/footer indicating restricted access. The previous detailed study information and navigation sections have been removed from view.
    Difference
    17%
    Check dated 2026-09-20T20:19:55.000Z thumbnail image

Stay in the know with updates to DCVax-L for Newly Diagnosed GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.